PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $51,548,000 | -31.1% | 671,287 | -63.1% | 0.04% | +29.4% |
| Q3 2015 | $74,782,000 | -67.8% | 1,819,516 | -44.6% | 0.03% | -82.2% |
| Q2 2015 | $232,394,000 | +52.4% | 3,286,470 | +91.5% | 0.19% | +51.6% |
| Q1 2015 | $152,518,000 | +49.4% | 1,716,578 | +49.1% | 0.13% | +44.8% |
| Q4 2014 | $102,066,000 | +4.7% | 1,151,202 | +14.5% | 0.09% | -2.2% |
| Q3 2014 | $97,487,000 | +15.3% | 1,005,855 | +9.3% | 0.09% | +15.6% |
| Q2 2014 | $84,520,000 | – | 920,097 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |